Fan et al. studied the penetrance and clinical outcomes of seven breast cancer susceptibility genes (ATM, BRCA1, BRCA2, CHEK2, PALB2, PTEN, and TP53) in 13,458 participants unselected for personal or family history of breast cancer. This evidence concerns the gene CHEK2 and breast cancer.